In a recent Nature paper, researchers have developed a new methodology to track the fates of cancer cells after therapy. […]
‘Insights into a new drug for non-Hodgkin’s lymphoma’ – Written by Charlotte Harrison, Science Writer. A team of researchers from […]
A recent study, carried out by researchers form the NIH’s National Eye Institute, has identified rare genetic variants that could […]
Codon-specific mutations in the KRAS gene may predict a patient’s response to harsh chemotherapy, according to a recent study published […]
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
The COVID-19 pandemic was controlled due to the rapid development of new vaccines and anti-viral drugs. However, the emergence of […]
Written by Lauren Robertson, Science Writer New research suggests some prostate cancer drugs may change how certain prostate tumours function, […]
Results from a clinical trial suggest that local delivery of anti-CTLA-4 immunotherapy drug is safer than systematic delivery. The study, […]
A new drug trial has eliminated 100% of rectal tumours in patients after 6 months. Published in the New England […]
Researchers at the University of Texas have performed genome-wide CRISPR screens to uncover vulnerabilities critical for discovering anticancer drugs. The […]
